Biohaven Ltd.
Symbol: BHVN (NYSE)
14.21
▲ (1.00%) 0.140
Company Description:
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Key Stats
- Today's Open: $14.21
- Today's High: $14.21
- Today's Low: $14.21
- Today's Volume: 10
- Yesterday Close: $14.07
- Yesterday High: $14.15
- Yesterday Low: $13.76
- Yesterday Volume: 1.65M
- Last Min Volume: 10
- Last Min High: $14.21
- Last Min Low: $14.21
- Last Min VWAP: $14.21
Company Profile
- Name: Biohaven Ltd.
- Website: https://www.biohaven.com
- Listed Date: 2022-09-23
- Location: NEW HAVEN, CT
- Market Status: Active
- CIK Number: 0001935979
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.48B
- Round Lot: 100
- Outstanding Shares: 105.79M
- Asset Type: CS
RECENT FILINGS FOR BHVN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | 8-K | View |
| 2025-08-15 | 8-K | View |
| 2025-08-15 | 424B7 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-06-04 | 8-K | View |
| 2025-05-15 | 8-K | View |
| 2025-05-14 | SCHEDULE 13G/A | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-07 | 8-K | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-05-07 | 4 | View |
| 2025-04-28 | 8-K | View |
Latest News on BHVN